𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)

✍ Scribed by Javier Ruiz-Martínez; Ana Gorostidi; Berta Ibañez; Ainhoa Alzualde; David Otaegui; Fermin Moreno; Adolfo López de Munain; Alberto Bergareche; Juan Carlos Gómez-Esteban; José F. Martí Massó


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
120 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The LRRK2 R1441G mutation was first identified in Basque families and it is responsible for 46% of familial Parkinson's disease (PD) and for 2.5% of sporadic PD in the PD population of Basque ascent. The aim of this study was to determine LRRK2 R1441G penetrance in PD in the Basque Country (Spain) to help in a more accurate genetic counseling. A total of 59 sibships containing 244 individuals, with a total of 40 PD‐affected relatives, were studied. Genetic testing for the R1441G mutation in the LRRK2 gene was performed in 133 individuals and was positive in 51% of them. Lifetime penetrance of R1441G mutations turned out to be 12.5% at 65 years to 83.4% at 80 years. No gender differences were found in penetrance. © 2010 Movement Disorder Society.


📜 SIMILAR VOLUMES


Neuropathology of Parkinson's disease wi
✍ José-Félix Martí-Massó; Javier Ruiz-Martínez; Maria J. Bolaño; Irune Ruiz; Ana G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract We report the neuropathological findings in a patient with Parkinson's disease (PD) associated with Basque R1441G‐__LRRK2__/dardarin mutation. The patient was a man with disease onset at 68 years of age, with unilateral rest tremor; the Parkinsonism was well controlled with medication f

Parkinson's disease due to the R1441G mu
✍ Javier Simón-Sánchez; José-Félix Martí-Massó; José Vicente Sánchez-Mut; Coro Pai 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract The recent discovery of mutations in Dardarin (__LRRK2__) have been related to the appearance of Parkinson's disease in several families. Notably, one single mutation in this gene (R1441G) not only appeared in familial, but also in apparently sporadic Parkinson disease (PD) patients of

Olfactory deficits and cardiac 123I-MIBG
✍ Javier Ruiz-Martínez; Ana Gorostidi; Estibaliz Goyenechea; Ainhoa Alzualde; Juan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor phase. However, it is not clear what value these tests have in all patients with Parkinson's disease and, particularly, in those wh

High frequency and reduced penetrance of
✍ María Sierra; Isabel González-Aramburu; Pascual Sánchez-Juan; Coro Sánchez-Quint 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract The frequency and penetrance of the LRRK2 G2019S mutation varies considerably in different Parkinson disease (PD) populations. This information is essential both for clinical purposes and genetic counseling. The objective of this study was to estimate the prevalence and penetrance of th

The G2019S LRRK2 mutation in Brazilian p
✍ Renato P. Munhoz; Yosuke Wakutani; Connie Marras; Helio A. Teive; Salmo Raskin; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Mutations in the Leucine‐Rich Repeat Kinase 2 gene (__LRRK2__) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of __LRRK2__ kindreds demonstrate an extremely

Burden of disease related to Parkinson's
✍ Esther Cubo; Elena Alvarez; Consuelo Morant; Jesús De Pedro Cuesta; Pablo Martín 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract We measured the burden caused by Parkinson's disease (PD) in Spain during the year 2000 and compared it against PD burden worldwide and in the European A subregion. Burden of disease (BoD) is an important factor in health policy. Disability‐adjusted life years (DALY) as a measure of BoD